data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Applied Genetic
(NASDAQ:AGTC)
$0.7801
0.0101[1.31%]
At close: Jul 1
$0.768
-0.0121[-1.55%]
After Hours: 4:33PM EDT
Day High/Low0.77 - 0.79
52 Week High/Low0.58 - 4.15
Open / Close0.78 / 0.78
Float / Outstanding50.6M / 50.7M
Vol / Avg.139.7K / 439.7K
Mkt Cap39.6M
P/E-
50d Avg. Price0.84
Div / Yield-
Payout Ratio-
EPS-0.45
Total Float50.6M

Applied Genetic (NASDAQ:AGTC), Quotes and News Summary

Applied Genetic (NASDAQ: AGTC)

Day High/Low0.77 - 0.79
52 Week High/Low0.58 - 4.15
Open / Close0.78 / 0.78
Float / Outstanding50.6M / 50.7M
Vol / Avg.139.7K / 439.7K
Mkt Cap39.6M
P/E-
50d Avg. Price0.84
Div / Yield-
Payout Ratio-
EPS-0.45
Total Float50.6M
Benzinga - 5 days ago
Benzinga - Jun 10, 2022, 4:24PM
Benzinga - May 18, 2022, 9:13AM
Benzinga - May 17, 2022, 6:39AM
Benzinga - May 16, 2022, 4:16PM
Benzinga - May 4, 2022, 8:09AM
Benzinga - Mar 22, 2022, 8:47AM
Benzinga - Mar 22, 2022, 8:34AM
Benzinga - Mar 21, 2022, 4:24PM
Benzinga - Mar 21, 2022, 4:01PM
load more
Sector: Health Care.Industry: Biotechnology
Applied Genetic Technologies Corp is a clinical-stage biotechnology company that uses a proprietary gene therapy platform to develop transformational genetic therapies for patients suffering from rare and debilitating diseases. Its initial focus is in the field of ophthalmology, where it has active clinical trials in X-linked retinitis pigmentosa, achromatopsia (ACHM CNGB3 and ACHM CNGA3), and X-linked retinoschisis. In addition to its clinical trials, company has preclinical programs in optogenetics, adrenoleukodystrophy, which is a disease of the central nervous system, other ophthalmology, and otology indications. The optogenetics program is being developed in collaboration with Bionic Sight.
Read More

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2022-09-22
REV
Q3 2022Est.ActualSurprise
EPS-0.430-0.330 0.1000
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Applied Genetic Questions & Answers

Q
How do I buy Applied Genetic (AGTC) stock?
A

You can purchase shares of Applied Genetic (NASDAQ: AGTC) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Applied Genetic's (AGTC) competitors?
Q
What is the target price for Applied Genetic (AGTC) stock?
A

The latest price target for Applied Genetic (NASDAQ: AGTC) was reported by Chardan Capital on Wednesday, May 18, 2022. The analyst firm set a price target for 5.00 expecting AGTC to rise to within 12 months (a possible 540.94% upside). 1 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Applied Genetic (AGTC)?
A

The stock price for Applied Genetic (NASDAQ: AGTC) is $0.7801 last updated July 1, 2022, 8:00 PM UTC.

Q
Does Applied Genetic (AGTC) pay a dividend?
A

There are no upcoming dividends for Applied Genetic.

Q
When is Applied Genetic (NASDAQ:AGTC) reporting earnings?
A

Applied Genetic’s Q4 earnings are confirmed for Thursday, September 22, 2022.

Q
Is Applied Genetic (AGTC) going to split?
A

There is no upcoming split for Applied Genetic.

Q
What sector and industry does Applied Genetic (AGTC) operate in?
A

Applied Genetic is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.